In vitro activity of imipenem-relebactam against KPC-producing Klebsiella pneumoniae resistant to ceftazidime-avibactam and/or meropenem-vaborbactam

MLA

Donatella Lombardo, et al. “In Vitro Activity of Imipenem-Relebactam against KPC-Producing Klebsiella Pneumoniae Resistant to Ceftazidime-Avibactam and/or Meropenem-Vaborbactam.” Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, vol. 28, no. 5, Oct. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....57b145fbdd8bfc8e2480570eea0b159a&authtype=sso&custid=ns315887.

APA

Donatella Lombardo, Simone Ambretti, Tiziana Lazzarotto, & Paolo Gaibani. (2021). In vitro activity of imipenem-relebactam against KPC-producing Klebsiella pneumoniae resistant to ceftazidime-avibactam and/or meropenem-vaborbactam. Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 28(5).

Chicago

Donatella Lombardo, Simone Ambretti, Tiziana Lazzarotto, and Paolo Gaibani. 2021. “In Vitro Activity of Imipenem-Relebactam against KPC-Producing Klebsiella Pneumoniae Resistant to Ceftazidime-Avibactam and/or Meropenem-Vaborbactam.” Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 28 (5). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....57b145fbdd8bfc8e2480570eea0b159a&authtype=sso&custid=ns315887.